Comparison of newly developed immuno-MS method with existing DELFIA®immunoassay for human chorionic gonadotropin determination in doping analysis

Bioanalysis ◽  
2013 ◽  
Vol 5 (5) ◽  
pp. 623-630 ◽  
Author(s):  
Hanne Lund ◽  
Ann Helene Snilsberg ◽  
Trine Grønhaug Halvorsen ◽  
Peter Hemmersbach ◽  
Léon Reubsaet
Keyword(s):  
Chorionic Gonadotropin ◽  
Human Chorionic Gonadotropin ◽  
Doping Analysis ◽  
In Doping

scholarly journals Performance Characteristic of the β-Human Chorionic Gonadotropin Assay on the Access 2 for Its Use in Doping Control

2010 ◽  
Vol 31 (10) ◽  
pp. 2889-2892 ◽  
Author(s):  
Min-Jung Kang ◽  
Hye-Im Lee ◽  
Sang-Mi Shin ◽  
Hye-Hyun Yoo ◽  
Oh-Seung Kwon ◽  
...  
Keyword(s):  
Chorionic Gonadotropin ◽  
Human Chorionic Gonadotropin ◽  
Performance Characteristic ◽  
Doping Control ◽  
In Doping

Human Chorionic Gonadotropin and CA 15-3 Producing Adenocarcinoma

1998 ◽  
Vol 37 (08) ◽  
pp. 297-298 ◽  
Author(s):  
A. Özet ◽  
A. Arpaci ◽  
S. Kömiircü ◽  
G. Üçkaya
Keyword(s):  
Lung Adenocarcinoma ◽  
Chorionic Gonadotropin ◽  
Human Chorionic Gonadotropin ◽  
Carbohydrate Antigen ◽  
Beta Subunit ◽  
Cancer Antigen ◽  
First Report ◽  
Primary Lung Adenocarcinoma ◽  
Adenocarcinoma Of Lung

Summary50 years old man suffering from primary lung adenocarcinoma presented with high levels of both beta subunit human chorionic gonadotropin (βHCG) and cancer antigen 15-3 (CA 15-3) in the absence of elevated carcinoembrionic antigen (CEA), alfa fetoprotein (AFP) and carbohydrate antigen 19-9 (CA 19-9). Although βHCG or CA 15-3 high levels were reported in adenocarcinoma of lung, this is the first report of a patient with high levels of both markers.

Sign in / Sign up

Export Citation Format

Share Document